Gerresheimer’s SensAIR platform for biologics infusion

SensAIR On-Body Infusor for high-viscosity drugs

0
18
Gerresheimer's new SenAIR platform for high-viscosity biologics infusion Photo Gerresheimer
Gerresheimer's new SenAIR platform for high-viscosity biologics infusion Photo Gerresheimer

With SensAIR, Gerresheimer has brought, for the first time, a new platform for on-body infusion pumps which can administer drugs of higher viscosity. The new platform implies the precise and safe infusion of drugs such as monoclonal antibodies (mAb).

The new device aims to provide patients with the best possible support in the subcutaneous delivery of large-volume biologics. The ready-to-use SensAIR On-Body Infusor is easy to use and enables patients to start medication in a self-determined manner in familiar surroundings, for example, at home.

The SensAIR On-Body Infusor can be adapted to many medications of different viscosities and different requirements. This applies to the size of the medical device and the needle used, variable cartridge sizes, and possible connectivity, for example, to the patient’s smartphone. With Gerresheimer’s One-Stop-Shop quality promise, which includes a solution from the cartridge to the drug delivery device from a single source, SensAIR enables the safe and optimized delivery of biologics.

“Everyone benefits from SensAIR – patients, their relatives, and also doctors. This device is an innovative medical device that, when worn on the body, delivers up to 20 ml of biologics subcutaneously to the patient,” says Oliver Haferbeck, head of the Advanced Technology & Innovation Unit Gerresheimer and CEO of Sensile-Medical. He explains that patients gain significantly in quality of life because they can administer their medication themselves, at home. The ready-to-use concept ensures that the patient does not have to carry out any lengthy and complicated preparation steps but can operate the device simply and safely.

More quality of life for the patient

To date, many patients with a wide variety of indications have to endure long and stressful infusions in a hospital setting to treat their condition. How much easier would it be if patients could carry out the treatment at home? SensAIR makes life easier for these patients. They can care for themselves over a more extended period and – depending on the indication – only need to visit the doctor or hospital for check-ups.

SensAIR is an innovative product platform for the infusion of large-volume and highly viscous biologics. Gerresheimer specialists jointly developed the technology, function, design, and construction of the platform, and the product is supplied from a single source.

Safety and cost-efficiency

The SensAIR Infusor is a safe and straightforward concept for cost-effective adaptation to different needs, especially patient needs. Gerresheimer offers a platform solution that provides a wide range of options regarding the biologic to be applied. The possibilities start with the drug flow rate (0.15-1.00 ml/min), through type (for example, glass cartridge) and volume (up to 20ml) of the primary packaging, to connectivity.

With this focus, SensAIR is attractive to the market even with varying quantities of devices per year, as existing developments and processes can be adapted in the shortest possible time. The existing technologies and know-how, which have already proven themselves in the market, are consistently pursued in SensAIR. This is a significant advantage in terms of time-to-market, among other things, by quickly enabling clinical trials.

Gerresheimer is both a partner for the SensAIR device and a supplier and manufacturer of the primary packaging, i.e., the cartridge containing the active ingredient. This quality or attribute represents significant added value as a long-term partner and system supplier.

LEAVE A REPLY

Please enter your comment!
Please enter your name here